amoxilidari.com

IDARI, the Infectious Disease & Antimicrobial Research Institute, is a non-profit organization based in Rockville, Maryland, dedicated to advancing antimicrobial research and promoting responsible antibiotic stewardship. Founded as a response to the urgent need for accessible clinical guidelines on amoxicillin, IDARI produces independent, peer-reviewed resources focused on amoxicillin pharmacology, dosing protocols, and the challenges of antibiotic resistance. The institute emphasizes evidence-based practices, offering comprehensive analyses of the safety profiles of amoxicillin and its brand-name formulation, Amoxil, as well as generic alternatives.

IDARI’s services include standardized dosing guidelines for 250mg, 500mg, and 875mg amoxicillin, bioequivalence studies comparing brand-name and generic formulations, and a safe sourcing guide to help patients obtain medications legally and safely. With a commitment to education and evidence, IDARI also supports healthcare providers and the public in understanding the significance of judicious antibiotic use to combat the growing threat of antibiotic-resistant infections.